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This work intent to study the biofouling formation on commercial nanofiltration membrane surface in absence or 
presence of BDNPA (2,2-dibromo-3-nitrilopropionamide) and antifouling. The study was conducted in 
permeation system with filtration cell with displacement tangential flow using commercial nanofiltration 
membrane (DK/Osmonics) at 15 bar for 8 days operation. In our experiments, we used DBNPA as a biocidal 
agent and an antifouling at concentrations of 300 and 5 ppm, respectively, and these products were added to 
seawater coming from the Galeão beach, RJ, Brazil. Our results showed no significant values in flow or sulfate 
ion percentage rejection, especially in the presence of anti-fouling. Results of  bacterial count [aerobic bacteria, 
anaerobic bacteria and sulphate-reducing bacteria (BRS)] in seawater before and after the use of the BDNPA 
reported a decrease in the number of micro-organisms, showing that the biocide has been effective, especially for 
BRS. There was biofilm formation on the membrane surface, observing also a decrease in sessile micro-
organisms when using products.  
Key-words: biocide, antifouling, biofouling, nanofiltration membrane 
II International Conference on Antimicrobial Research - ICAR2012 
              Lisbon (Portugal) 21-23 November 2012
285
Blocking of Pseudomonas aeruginosa biofilm formation by a colistin coating
D. Alves1, H. Lopes, I. Machado and M. O. Pereira1
1Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, Campus de 
Gualtar, 4710-057 Braga, Portugal 
Bacterial colonisation of indwelling devices followed by biofilm formation remains a serious threat in clinical 
field as it is commonly associated to persistent infections. Once adhered to a surface, bacteria embed themselves 
in a self-produced matrix mainly composed of extracellular polymeric substances which confers them protection 
against antimicrobial agents and the host immune system. Early bacterial adhesion is a crucial step in biomaterial 
associated infections pathogenesis, representing therefore a promising target for the development of biofilm 
preventive measures. Several strategies have been developed to prevent bacterial adhesion and biofilm formation 
on the surfaces of medical devices, based mainly on the use of anti-adhesive, antiseptic and antibiotic coatings. 
Although some of these coatings have been shown efficient in the prevention of biofilm formation, an important 
drawback associated to them is the development of microbial resistance that limits the usefulness of classical 
antimicrobials. A promising solution to overcome this problem may rely on the use of new alternatives, as 
antimicrobial peptides (AMPs) that are unlikely to induce any resistance because of their evolutionary path. 
The aim of this work was to evaluate the potential role of colistin, a traditional AMP, as an antimicrobial coating 
for biomaterials. Based on the observation that the presence of colistin as a biofilm growth media complement 
was able to significantly impair Pseudomonas aeruginosa biofilm formation at concentrations below its MBC, 
polystyrene (PS) surfaces were coated with this AMP and its ability to prevent biofilm formation was assessed.  
A P. aeruginosa reference strain (ATCC 10145) and a P. aeruginosa clinical isolate (U147016) were used as 
biofilm producers. PS surfaces were pre-coated with several concentrations of colistin and the biofilms formed 
on conditioned and clean surfaces were then characterized in terms of biomass (CV), respiratory activity (XTT) 
and number of viable cells (CFU). The susceptibility of biofilms formed on colistin-conditioned surfaces to 
ciprofloxacin (CIP) treatment was further investigated. 
Results showed that the clinical isolate produces biofilms with more activity, less biomass and similar number of 
cells than the reference strain. Random deposition of colistin residues on the adhesion surfaces significantly 
reduced biofilm activity and mass accumulated in a dose-dependent manner for both strains. Regarding biofilm 
entrapped cells, the conditioning film proved to be less efficient, causing significant reductions for the highest 
concentrations tested. Concerning the combined application of colistin surface conditioning and biofilm 
treatment with CIP, it was observed that biofilms formed on colistin-conditioned surfaces were more susceptible 
to CIP treatment in terms of biofilm-entrapped cells. The presence of colistin during biofilm formation may have 
interfered in the transition from reversible to irreversible interactions during the early steps of bacterial adhesion 
to PS, disturbing and delaying the mature biofilm development. 
Biomaterial associated infections remains a major drawback to the long-term use of medical devices. This study 
demonstrates the potential of the AMP colistin as an excellent candidate for biomaterials coating limiting biofilm 
formation on their surfaces. 
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